Article
Breast cancer lncRNA-microRNA categories: new targets for therapeutic intervention
2023-11-15
Abstract excerpt
Breast cancer therapy may fail due to the disease's limiting pathogenesis processes, including as epithelial-mesenchymal transition (EMT), cancer stem cells (CSCs), and drug resistance. Functionally significant mediators in these pathogenic processes include lncRNAs and miRNAs, which are master regulators of gene expression. Complex regulatory networks of post-transcriptional gene control are formed by the intrica...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e94dea54-3e18-51a9-b2b5-7c7f60cc5377
- DOI
- 10.22541/au.170000971.13079306/v1
